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Abstract: Community pharmacy-based provision of immunizations in the USA has become 
commonplace in the last few decades, with success in increasing rates of immunizations. 
Community pharmacy-based vaccination services are provided by pharmacists educated in the 
practice of immunization delivery and provide a convenient and accessible option for receiving 
immunizations. The pharmacist’s role in immunization practice has been described as serving in 
the roles of educator, facilitator, and immunizer. With a majority of pharmacist-provided vac-
cinations occurring in the community pharmacy setting, there are many examples of community 
pharmacists serving in these immunization roles with successful outcomes. Different community 
pharmacies employ a number of different models and workflow practices that usually consist 
of a year-round in-house service staffed by their own immunizing pharmacist. Challenges that 
currently exist in this setting are variability in scopes of immunization practice for pharmacists 
across states, inconsistent reimbursement mechanisms, and barriers in technology. Many of 
these challenges can be alleviated by continual education; working with legislators, state boards 
of pharmacy, stakeholders, and payers to standardize laws; and reimbursement design. Other 
challenges that may need to be addressed are improvements in communication and continuity 
of care between community pharmacists and the patient centered medical home.
Keywords: immunization, pharmacy practice, pharmacists, continuity of care
Background
An estimated 40,000 to 50,000 adults die annually from vaccine-preventable disease in 
the USA.1 Treating these patients who go without routine and recommended vaccinations 
costs the health care system US$10 billion each year.2 Adult vaccination rates for routine 
recommended vaccines in the USA are low, and well below projected Healthy People 
2020 targets.3,4 An example of this is the annual influenza vaccination, which is recom-
mended for all people $6 months of age. The most recent Centers for Disease Control 
and Prevention (CDC) data, from the 2012–2013 influenza season, revealed an influenza 
immunization rate of 45% in all people 6 months of age and older. There is also drastic 
variability in coverage among different age groups. In adults 18 years and older, the influ-
enza vaccination rate increased with increasing age – from 31.1% in those 18–49 years of 
age to 66.2% in those $65 years of age.5 Looking at other vaccines, the pneumococcal 
polysaccharide vaccination rate for high-risk patients aged 19–64 years of age was 20%.3 
The Advisory Committee on Immunization Practices recommends a single dose of zoster 
vaccine for all adults aged 60 years and older, whether or not they report a prior episode 
of herpes zoster.6 However, overall, the shingles vaccination rate is only 20.1%.3 These 
are just a few examples of the low immunization rates seen today in the USA.
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The underutilization of these widely available vaccines 
has created an opportunity for pharmacists to play a role in 
improving immunization rates and thus advancing public 
health. Community pharmacy-based vaccination services 
have increased the number of immunization providers and the 
number of sites where patients can receive  immunizations. 
It is thus important to understand the current role of com-
munity pharmacy-based immunization programs in the USA 
to identify opportunities and challenges for improving the 
public-health infrastructure to deliver vaccinations.
Objectives
This review explores the roles of the pharmacist as educator, 
facilitator, and immunizer in community pharmacy-based 
vaccination services. The review also touches on the journey 
to pharmacist as providers of vaccinations, delivery models, 
barriers, and future directions in the area of pharmacy-based 
vaccination services.
Pharmacists as providers  
of vaccinations
With 93% of Americans living within 5 miles of a commu-
nity pharmacy, community pharmacists are one of the most 
readily accessible health care professionals in America.7 In 
2011–2012, 20.1% of US adults received their influenza 
vaccinations from a supermarket or drug store – an increase 
from 18.4% during the 2010–2011 season.8,9 With multiple 
locations in metropolitan and urban areas, extended hours, 
reduced cost to administer vaccines,10 and convenience, com-
munity pharmacies address many factors that can increase 
immunization rates.11,12 According to the US Bureau of 
Labor Statistics, there were 286,400 pharmacist jobs in 
2012.13 An estimated 51% of these pharmacists work in the 
39,000 chain and 23,117 independent community pharmacy 
locations across the USA.7,14 Patients often report that their 
preference for receiving vaccinations in a pharmacy or 
from a non-physician in a nontraditional setting is due to 
convenience.15–17 Most immunizing community pharma-
cies provide vaccinations without an appointment, require 
almost no waiting, and do not charge visit fees. Community 
pharmacy hours of operation also provide extended access 
outside of traditional settings, such as a physician’s office, 
which has limited hours after 5 pm and is usually closed on 
the weekends and holidays. When immunizations are offered 
through community pharmacies during these “off-hours”, 
large numbers of patients take advantage of the increased 
access and convenience, especially those younger, healthier 
adults in whom rates of immunizations tend to be lower.18 
In addition to capturing the younger, healthier population, 
community pharmacies have been able to reach medically 
underserved and difficult-to-reach populations.11,19 Commu-
nity pharmacies offering vaccinations serve to complement 
the health care system to increase the number of providers 
and settings from which patients can receive vaccines.
As the pharmacy profession continues to move away 
from strictly product distribution to direct patient care, so 
does the education and training of pharmacists. Since 2000, 
the doctor of pharmacy (Pharm D) degree has been the sole 
degree offered to pharmacy graduates in the USA. All pro-
fessional programs that graduate students with the Pharm 
D undergo accreditation by the Accreditation Council for 
Pharmacy Education (ACPE), which has set standards for 
professional competencies and outcome expectations of 
Pharm D  graduates. In the 2006 Accreditation Standards 
and Guidelines for the Professional Program in Pharmacy 
Leading to the Doctor of Pharmacy Degree (hereafter, “ACPE 
Standards”), standard number 12 notes that the professional 
pharmacist competencies that must be achieved by graduates 
through the Pharm D curriculum are the ability to: provide 
patient-centered care; provide population-based care; manage 
human, physical, medical, information, and technological 
resources; manage medication-use systems; and promote 
the availability of effective health and disease-prevention 
services and health policy.20 It is the emphasis on providing 
population-based care and disease-prevention services that 
has prepared pharmacists to provide public-health services, 
which would include efforts to increase immunization rates, 
reach at-risk populations, and decrease the incidences and 
mortality of vaccine-preventable diseases. The ACPE Stan-
dards 2016 has now explicitly listed under the public-health 
domain that “[providing] an avenue through which students 
become certified in immunization delivery”21 is a required 
element of any Pharm D curriculum. In addition to a cur-
riculum that produces pharmacists capable of identifying and 
solving public-health issues, the Pharm D graduate’s training 
and expertise lies with pharmaceuticals. Since vaccines and 
biological products are approved by the US Food and Drug 
Administration and considered prescription (pharmaceutical) 
products, pharmacists are uniquely qualified to not only serve 
as drug experts but also vaccine experts as well.
Pharmacy-based immunization training for pharmacists 
also follows a nationally adopted certificate training pro-
gram developed by the American Pharmacists Association 
(APhA), and the quality and content of this program in 
preparing pharmacists to administer vaccines are recognized 
by the CDC’s National Immunization Program.22 The APhA 
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Pharmacy-Based Immunization Delivery program involves 
three components: 1) a 12-hour self-study that covers immu-
nology, vaccines, patient care, practice implementation, and 
legal and regulatory issues; 2) a live 8-hour program that 
reinforces and expands on the self-study content and focuses 
on immunization decision-making and pharmacy-practice 
implementation; and 3) a practicum that assesses subcutane-
ous and intramuscular injection techniques.23 This program 
has trained more than 150,000, and counting, pharmacists 
and student pharmacists nationwide.22,24
With the public’s increased ability to access pharmacists, 
pharmacists are perfectly positioned and have notable train-
ing to engage in conversations with patients to prompt vac-
cine reminders and recommendations, and dispel myths and 
misconceptions regarding vaccinations.25 In addition to this, 
pharmacists have consistently ranked as one of the top three 
most honest and ethical professions in the USA.26
Journey to pharmacist-provided 
vaccinations in the USA
Although community pharmacies and pharmacists are 
recognized today by the CDC and the US Food and Drug 
Administration as established nontraditional settings and 
providers, most of this achievement took place just within 
the last two decades. Pharmacy involvement with vaccines 
and immunization in the USA has been noted since the 
mid-1800s but was limited in function, with pharmacies 
serving as a source of storage, preparation, distribution, 
and education, and as hosts of immunization providers 
in their practice.22,27 In 1993, then-secretary of the US 
Department of Health and Human Services (DHHS) 
Donna Shalala requested the APhA to define the role of 
pharmacists in improving vaccination rates. The APhA’s 
response was successful in getting the DHHS to officially 
recognize that pharmacists are able to play an integral role 
in vaccine education, mobilization, distribution, access, 
record keeping, administration, and, ultimately, improving 
vaccination rates.22 From this, the first organized immuniza-
tion training program for pharmacist-administered immu-
nizations took place in Seattle, Washington, in late 1994. 
Pharmacists’ movement into adult immunization came in 
1996 and resulted from collaboration between the Missis-
sippi Pharmacists Association and the APhA to address 
the Mississippi Department of Public Health’s request for 
pharmacists in resolving the disparities in adult influenza 
and pneumococcal rates. This effort lead to the development 
of the now nationally recognized APhA Pharmacy-Based 
Immunization Delivery certificate program.22
Turf wars with physicians continue to be a challenge as 
pharmacists look to expand the ages of patients they can 
vaccinate, the types of vaccines they can administer, and 
their responsibilities by becoming independent providers of 
 immunizations. The American College of Physicians supports 
pharmacists as a source of immunization information, facili-
tators of immunizations, and as immunizers, as appropriate 
and allowed by state law.28 In March of 2014, the National 
Vaccine Advisory Committee published its recommendations 
for adult immunization standards.29 These recommendations 
call for all providers, including pharmacists, to implement 
policies and processes that increase adult vaccination. Most 
mainstream medical and allied health care provider organiza-
tions have signed on to promote this document. While there 
has been widespread support of pharmacy-based immuni-
zation programs under collaborative practice agreements, 
physician resistance and attitudes tend to be less favorable 
when community pharmacists take on an independent role 
in patient care.30,31 These opinions may vary among states, 
as an example of support was the California Association of 
Physician Groups helping California pharmacists achieve 
provider status and independent immunization practice in 
2013 under Senate Bill 493.32,33
State-based pharmacist 
immunization laws
In the USA, all health care is delivered based not on 
federal but state law. Currently, all 50 states in the USA, 
and  Washington DC and Puerto Rico, allow pharmacists 
to administer vaccinations. However, among states, laws 
vary for the need for a protocol and/or prescription to give 
a vaccine, minimum age limit, and the vaccines pharma-
cists are authorized to administer. The latest APhA and 
National Alliance of State Pharmacy Associations’ survey 
of state immunization laws/rules, report that 31 states 
require  pharmacist-administered vaccines to be pursuant 
to a protocol or prescription, while 12 allow for a protocol, 
prescription, or no prescriber needed (depending on the age 
and/or vaccine).34 The remaining states and US territories 
allow pharmacists to administer vaccines via protocol only 
or prescription only. Regarding age and types of vaccines, 
27 states do not have a patient age limitation for pharmacist-
administered vaccines, and 46 states currently authorize 
pharmacists to administer any type of vaccine. Patient age 
limitations in states range from those 5 years of age or older 
to those greater than 18 years of age. State laws also vary in 
the authority for student pharmacists to administer vaccines 
(eight states do not allow student pharmacists to vaccinate). 
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The State of California was the most recent state to move 
from a 1995 law that allowed pharmacists to “administer 
immunizations pursuant to a protocol with a prescriber” to 
independent initiation of vaccines for those 3 years of age 
and older.35 Information on current state laws pertaining to 
pharmacist authority to immunize is updated regularly on 
the APhA’s Immunization Center  webpage (http://www.
pharmacist.com/immunization-center).
Role of the pharmacist  
in immunizations
In 1997, the APhA published a set of guidelines for pharmacy-
based immunization advocacy that can still be applied today 
to the role of community pharmacists in  immunizations.36 
The organization encourages all pharmacists to adopt a 
level of involvement in vaccinations as either an educator 
 (encouraging immunizations to patients served), facilitator 
(serving as a depot for vaccine distribution or host for immu-
nizers), or immunizer (administering vaccinations consistent 
with state law).36 Today, community pharmacists still serve in 
vaccine advocacy roles within their practice setting.
Although this review focuses on the role of community 
pharmacists in providing vaccinations, it is worth noting that 
pharmacists also play an important role in immunizations 
in the inpatient and health-systems setting. In this setting, 
pharmacists primarily serve as educators and facilitators to 
increase immunization rates. As part of the health care team, 
pharmacists provide immunization screening and recom-
mendations for at-risk patients, carry out standing orders 
with nursing staff, and develop protocols and collaborative 
agreements with physicians.22,37–39 Guidelines on the pharma-
cists’ role in immunization in the inpatient or health-systems 
setting have been published by the  American Society of 
Health-System Pharmacists (http://www.ashp.org/s_ashp/
docs/files/BP07/Specific_Gdl_Immun.pdf [accessed May 14, 
2015]).40
The remainder of this review highlights the roles 
and contributions of community pharmacists as vaccine 
providers through the roles of educators, facilitators, and 
immunizers.
Pharmacists as vaccine educators
Community pharmacists are valuable sources of informa-
tion for patients. As vaccine educators, pharmacists act to 
educate and recommend to the patients the importance of 
and need for receiving vaccinations. Physician views toward 
the community pharmacist’s role in patient advocacy include 
assisting physicians in monitoring pharmacotherapy, and 
providing patient counseling and medical information.30,41 
The coordination and education regarding the importance 
of receiving routine and recommended vaccinations, and 
the vaccine product itself, would fall into this view of com-
munity pharmacists as sources of information. As discussed 
earlier, pharmacists have been trained in providing clinical 
services and patient communication; it is only appropriate 
that they employ this training in advocating vaccinations. 
Pharmacist-provided patient vaccine education, screening, 
and recommendations have been shown to increase vac-
cination rates.42
Pharmacists have been successful in their role as vac-
cine educators by screening patients and providing rec-
ommendations to patients and providers. As providers of 
medication therapy management and a source of patient 
medication records, community pharmacists are able to 
identify patients at risk for vaccine-preventable diseases 
through use of pharmacy data and patient interviews.43,44 
In an interview of seniors taking three or more medica-
tions concurrently according to pharmacy records, the most 
common pharmacist- identified drug-related problems were 
“patient required drug therapy” or “patient requires influenza 
or pneumococcal vaccination”.43 Pharmacists are able to 
review prescription records to create “inferred diagnosis” 
when the medical record is not available, and identify the 
need for a specific vaccination. For example, screenings for 
the pneumococcal vaccine can target those 65 years of age 
or older, those with immunocompromising medications, 
those with respiratory or diabetes medications; or the Tdap 
(tetanus, diphtheria, and pertussis) vaccine for females with 
prenatal prescriptions or picking up infant-care  supplies. This 
information can be obtained from the patient’s pharmacy 
profile and prescription history in the pharmacy informa-
tion management system (PIMS). The screening for and 
recommending of vaccinations are part of the pharmacist’s 
responsibility in monitoring drug therapy, and includes iden-
tification of lack of therapy and preventative measures such 
as routine and recommended vaccinations.
Community pharmacists also educate the community 
through awareness campaigns and distributing literature 
on the need for vaccination and where to obtain the needed 
vaccinations. Using a combination of screening pharmacy 
records, distributing vaccine literature, and urging vaccina-
tion, community pharmacists in the Isle of Wight, England, 
vaccinated 9.7% of all patients who received influenza vac-
cine on the island during the 2010–2011 influenza season. 
They also noted that it was a pharmacy staff reminder that 
led to the initiation of two-thirds of these vaccinations.45 
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Similar results exist for pharmacist-driven interventions for 
the zoster vaccine. Pharmacists and pharmacy staff who pro-
moted the zoster vaccine and provided personal selling and 
patient education were able to increase the number of zoster 
vaccinations compared with when there was no pharmacist 
intervention.46–49 With a lack of physician recommendation to 
patients and patients’ misassumption of their perceived need 
for vaccinations, pharmacists can recapture these patients and 
engage them in conversation about needed vaccinations.50 
The pharmacist’s role as a vaccine educator enhances patient 
adherence to vaccinations through initiating an open discus-
sion, providing education, and patient follow-up with the 
pharmacist. These techniques are similar to those employed 
in the pharmacist’s role in improving patient adherence to 
other medications.51
Pharmacists as vaccine facilitators
As discussed earlier, early pharmacist involvement with 
immunizations was limited to the distribution of vaccine 
products and hosting of immunization providers in their 
 pharmacy. Community pharmacists facilitated immuniza-
tions given by other health care providers, such as physi-
cians and nurses, by providing their pharmacies as venues 
to provide vaccines. Hosting other providers was usually 
limited to 2–3 days during the fall and for a short number 
of hours during each event. Revenue generated from such 
events was also retained by the providers of immunization, 
and the pharmacy benefited through goodwill and collateral 
sales.52 However, with all states currently allowing pharma-
cists to immunize, modern community pharmacists now use 
their pharmacies to host their own immunization services 
year-round. This movement away from being distributors 
or facilitators to being full providers of immunizations may 
explain the scarce literature on the role of pharmacists as 
vaccine facilitators and distributors.
As vaccine distributors, pharmacies facilitate other pro-
viders in administering vaccinations by ordering and distrib-
uting vaccine products to physicians and medical clinics. In 
a random sample of community pharmacies from 17 states, 
about one in five pharmacies engaged in vaccine distribution 
by reselling or distributing vaccines to local physicians and/
or clinics.53 Common vaccines that were distributed to other 
providers for administration were the hepatitis A, hepatitis 
B, meningococcal, MMR (measles–mumps–rubella), and 
tetanus-containing vaccines.54 Although this is a minor role 
for pharmacy, it should be continued. A survey of family 
practitioners and general internists revealed that many pri-
mary care providers (PCPs) do not stock all recommended 
adult vaccines, with only 12% planning to increase their 
offerings and 2% planning to stop altogether.55 With barriers 
in reimbursements for pharmacy-administered vaccinations, 
some patients insist on receiving vaccinations from their 
PCP because it is covered under their medical benefits. In 
this case, PCPs will need access to vaccines they do not 
normally stock.
The pharmacist’s role as a facilitator improves immu-
nization rates by increasing other health care providers’ 
accessibility to vaccine products and the locations where 
these providers can offer immunization services. In this role, 
pharmacists also aid other providers in improving their immu-
nization offerings and rates of immunizations. It is important 
to note that while community pharmacists no longer serve 
in the originally defined role of facilitators (hosting other 
providers of immunizations), serving as facilitators was 
important in the progression of community pharmacists 
to immunizers by presenting the public with the concept 
of vaccination delivery in the pharmacy setting. For coun-
tries looking to implement pharmacy-based immunization 
delivery services, we suggest pharmacies serve as vaccine 
facilitators to trial immunization services in the pharmacy 
and expose the public and health system to vaccine delivery 
occurring in the community pharmacy.
Pharmacists as immunizers
According to the APhA Annual Pharmacy-Based Influ-
enza and Adult Immunization Survey 2013, pharmacists 
provide vaccinations in 86% of community pharmacy 
settings. Patients are also increasingly being referred to 
the pharmacy from their PCP for immunizations by the 
pharmacists.56 With pharmacists authorized to administer 
vaccines in all 50 states, the most effective and efficient 
pharmacist role for providing vaccination services is to 
serve as an immunizer. As active immunizers, pharmacists 
assess patients for indications and contraindications and 
administer vaccines directly to the patients that they serve. 
Immunizing pharmacists follow the recommendations and 
immunization schedules provided by the Advisory Commit-
tee on Immunization Practices and the CDC. In a review of 
interventions to increase influenza and pneumococcal vac-
cination rates among community-dwelling adults, results 
showed that pharmacist interventions were ineffective when 
pharmacists only gave reminders to physicians and did not 
themselves administer the vaccinations.57 This role as an 
immunizer offers pharmacists the ability to deliver com-
plete and successful immunization services by combining 
the roles of vaccine educator and immunizer.
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The literature is abundant with data supporting the role 
and impact of community pharmacists as immunizers. 
Community pharmacy-based immunization services are a 
cost-effective, convenient, and accessible alternative for the 
public to receive vaccinations.10,15 As stated earlier, one of 
the greatest barriers to vaccinations is accessibility. With 
pharmacists as immunizers, pharmacists are able to imme-
diately act on their recommendations (administer the patient 
the vaccine) without referring the patient elsewhere, where 
the patient may not follow through or forget. With increased 
accessibility, pharmacists have helped to improve immuni-
zation rates, bring patients up-to-date on vaccinations, and 
reach those who may not otherwise have an opportunity to 
be vaccinated.11,18,45,58–60 When comparing patients 50 years 
or older who obtained their medications from a community 
pharmacy to those that did not, community pharmacy patients 
had a higher rate of receiving the influenza immunization.61 
Prior to all states allowing pharmacists to provide vaccina-
tions, states that allowed pharmacists to vaccinate were 
associated with higher influenza vaccination rates for those 
65 years and older.62 In emergency-response situations 
requiring mass vaccinations, pharmacist immunizers, with 
a higher patient-to-practitioner ratio, have also been able to 
reach a larger portion of the community than other types of 
vaccine providers.63
Practice model
An outsourced or in-house approach can be taken to imple-
menting immunization services inside the community 
 pharmacy.64 In the outsourced model, pharmacies may 
contract with other professionals, notably nurses, to provide 
immunization services within the pharmacy during certain 
months, for example, influenza season and back to school 
months. The outsourced approach is essentially pharma-
cies participating in the vaccine facilitator role. Using an 
outsourced mechanism does not require much commitment 
from the hosting pharmacy beyond providing space in the 
pharmacy for the contracted immunization provider to work. 
Outsourced immunization services also require minimal 
pharmacy staff participation, allow for the trial of immuni-
zation services within the pharmacy, and are less likely to 
disrupt dispensing activities.64 This model is no longer used 
in US community pharmacies, since most pharmacies have 
an immunization-trained pharmacist on staff to carry out the 
vaccine-administration services within their own pharmacy.
Community pharmacies tend to utilize their immunization-
trained staff pharmacists to deliver all aspects of the immuni-
zation service alongside their distribution services. This is the 
second approach to implement pharmacy-based immunization 
services and is known as an in-house vaccination service. Of 
the two mechanisms to deliver pharmacy-based immuniza-
tion services, the in-house vaccination service offers the most 
effective and constructive outcome to public health and the 
pharmacy profession. As stated before, in-house services, 
where pharmacists are immunizers, improve vaccination 
rates and increase access/ convenience for patients.44,45,59,61 
In-house pharmacy immunization services have also been 
shown to be more cost-effective compared with physician 
office vaccinations.10 Unlike the outsourced method, in-house 
services are able to provide a wider range of vaccines year-
round in the pharmacy and allow the pharmacy to retain the 
revenue generated from the immunization services.52 These 
in-house services improve the pharmacy business by bringing 
in revenue; patient care, by increasing vaccine and vaccine-
provider access for patients; and the pharmacy role/profes-
sion, by expanding the role of clinical pharmacy services.65 
Some published guides are available to assist pharmacists in 
developing and implementing clinical pharmacy services in 
the community setting.66,67
Pharmacist-provided immunizations typically require 
a protocol with a physician, similar to the standing orders 
that nurses, nurse practitioners, and physician assistants 
may operate under.24 Depending on the specific state’s laws 
and regulations, pharmacists may initiate and administer 
vaccines under a collaborative practice agreement, pro-
tocol, or prescription order. The source and authorization 
of pharmacists provided with immunization protocols or 
standing orders are driven by the individual state’s laws and 
regulations. In general, protocols allow one physician to 
sign for multiple pharmacists and all patients who present 
to the pharmacy. While the protocol is currently the most 
common authorization for pharmacists to immunize, it can 
also serve to limit immunization access. Protocols cannot 
be more liberal than a state law, but they can be stricter. For 
example, physicians or organizations may, for example, raise 
the age limit; prohibit the vaccination of pregnant women; 
or require a prescription for pediatric vaccines, even though 
state law does not require it. Lastly, it may be difficult for 
independent pharmacists to find a physician to sign their pro-
tocol because the physician may perceive there to be greater 
liability than there really is or lack of a financial incentive. 
Chain pharmacies often either employ their protocol physi-
cian or are able to provide enhanced liability protection and 
financial incentives to a protocol physician.
The delivery and workflow of an in-house community 
 pharmacy immunization service varies from pharmacy 
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to pharmacy. Immunization services can be provided by 
appointment, on a walk-in basis, or a combination of both. 
The Annual Pharmacy-Based Influenza and Adult Immuni-
zation Survey 2013 reported that a majority of pharmacy 
practice sites offer vaccinations on a walk-in basis, with an 
increasing trend for pharmacies to adopt the walk-in service.56 
Appointment-based services tend to be less disruptive to the 
pharmacy’s normal workflow, as patient volume is planned 
and expected, however it can limit the number of patients 
who can be vaccinated. Walk-in-based services are more 
convenient for patients but may cause disturbances to the 
normal pharmacy workflow to accommodate the patients. 
Walk-in services might also mean that the pharmacy has 
to stock a wide range of, if not all, vaccines at all times 
because the requested vaccine and patient screening cannot 
be determined in advance. The time it takes to provide the 
comprehensive vaccination service can vary depending on 
the number of pharmacists or student pharmacists available; 
pharmacy dispensing volume; insurance billing versus paying 
out-of-pocket; and patient screening, counseling, and educa-
tion needs. The actual time it takes to administer the vaccine 
may only take 5 minutes or less.68
Other essential workflow and physical pharmacy environ-
ment needs for an in-house immunization service are a private 
patient-care area, adequate vaccine storage equipment, and 
emergency-response preparedness. While most pharmacies 
have been designed without private patient exam rooms, 
offering an immunization service only requires a semiprivate 
patient-care area. Pharmacies offering immunizations and 
patient-care services have met this need by repurposing exist-
ing space, or some have required remodeling of the physical 
pharmacy floor plans. A pharmacy providing vaccination 
services is also required to have adequate refrigeration and 
freezer equipment to ensure the potency and safe storage of 
vaccine products. Pharmacists who provide immunizations 
should also be adequately prepared for the management of 
adverse reactions that may occur. These may range from 
injection-site reactions and syncope to more severe reactions 
such as anaphylaxis. In addition to clear written protocols on 
the management of these reactions, immunizing pharmacists 
should be trained in cardiopulmonary resuscitation and have 
emergency supplies that consist of epinephrine, diphenhy-
dramine, a blood pressure cuff, and a stethoscope. Upon 
completion of the injection, patients are asked to remain 
seated in the pharmacy for observation for approximately 
15 minutes for any immediate syncopal or anaphylactic 
reactions. The CDC has published  general  recommendations 
 regarding communicating risk and  benefits,  administration 
and  storage, management of adverse events, special popula-
tions, record keeping, and resources for clinicians involved in 
the delivery of immunization services.69 The National Vaccine 
Advisory Committee has also provided recommendations 
for the standards of adult immunization practices to improve 
immunization practice and policy development.70,71
Current challenges
Despite the successes, community pharmacy-based vac-
cination services still face some challenges. Barriers noted 
include variability in laws at the state level regarding pharma-
cists’ administration of vaccines, inconsistent reimbursement 
and compensation systems, and barriers to accessing health 
information technology. Although pharmacists in all 50 states 
and US territories are authorized to administer vaccines, 
the process (allowed under protocol, standing order, and/or 
prescription), patient age, and type of vaccine permitted vary 
considerably. These scopes of practice are determined indi-
vidually at the state level, and the variability and limitations 
of some state regulations restrain the ability of pharmacists 
to fully contribute to immunization public-health efforts. 
The lack of recognition by all states that pharmacists are 
appropriately trained and professionally competent provid-
ers of immunizations who are able to increase the rate of 
vaccinations and improve public health may explain why 
some states still place limits on pharmacist immunization 
authorities. Individual states, with their pharmacists and local 
pharmacy associations, should continue to work with their 
state pharmacy boards and other stakeholders to advance their 
immunization scope of practice. This lack of wide recognition 
is also said to be the reason why inconsistent reimbursement 
designs for pharmacy-provided immunizations exist.25
For community pharmacy-based vaccination services, 
a limited number of commercial and governmental health 
plans offer patients coverage for receiving vaccinations 
from a pharmacy, and, even when provided, they do not 
always cover all recommended vaccines.72 For example, 
Medicare covers the pneumococcal and influenza vaccine 
in the pharmacy under the Part B medical benefits, but the 
shingles vaccine is covered under the Part D prescription 
benefits. This may also be a barrier for patients looking to 
receive a set of vaccinations from their PCP, who cannot bill 
under prescription drug benefits. Generally, for commercial 
health plans, if a vaccine is not covered under the pharmacy 
benefits, it is covered under the patient’s medical benefits, 
which the pharmacy may have difficulty billing. Limited or 
restricted benefits for pharmacy-provided immunizations 
mean that the patient either has to go elsewhere or pay high 
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out-of-pocket fees. This may result in the patient skipping the 
vaccine altogether or deferring vaccination. This is further 
complicated by the fact that most patients like the conve-
nience of going to a pharmacy versus making an appointment 
with their PCP, and that many may seek vaccinations after 
normal physician office hours.18  Immunization services carry 
a cost for the vaccine product itself and for the cost of the 
administration. For physicians and for pharmacists, many 
times, the reimbursements barely cover the cost of the vac-
cine product and administration, resulting in no net revenue 
or even a loss.73,74 Immunization stakeholders believe that if 
all CDC-recommended vaccines can be billed from either 
the pharmacy or medical benefit (with uniformity in cost 
sharing and reimbursement for product and administration 
cost across all provider types), it will decrease the barriers 
to patient access to immunizations and incentivize pharma-
cies (and other immunizers) to increase their immunization 
offerings and efforts.24 As medical care efforts increasingly 
focus on preventative measures in accordance with the 
Affordable Care Act (2010), there are increased incentives 
for benefit designs to include pharmacy-based vaccination 
benefits.72 Pharmacists are also encouraged to work with 
private employers/employer plans to seek further avenues for 
reimbursements and reaching more of the public.
There are also barriers in technology that exist in this set-
ting; from a lack of shared patient record systems to inadequate 
PIMSs that provide patient-specific immunization notifications 
and scheduling of patients. Currently, only about 63% of 
pharmacy immunization sites surveyed provide documentation 
of patients’ immunization directly to the PCP, and only 35% 
report to an immunization registry (with another 11% stating 
pharmacists are not permitted access to their state or local 
immunization registries).56 A lack of patient record systems 
shared with the patient centered medical home (PCMH), the 
PCP charged with coordinating care, has led to inconsistent 
communication between pharmacists and PCPs regarding 
patients’ current immunization status and records. Also, 
variability exists in state-level laws regarding mandates for 
pharmacists and other immunization providers to report to the 
state’s immunization information system (IIS) or immunization 
registries.75 The IIS gathers data on patients’ immunization 
records from a variety of immunization providers in the hope of 
compiling a complete record for continuity of care and public 
health. Immunization registries in which not all providers and 
all vaccines are mandated to be entered provide an incomplete 
record of an individual’s immunization status, possibly leading 
to under- or over-vaccination. Some challenges conveyed for 
pharmacy IIS reporting are that many PIMSs cannot directly 
communicate with the IIS; time-consuming paperwork and 
disruption of workflow; and lack of standard reporting man-
dates, procedures, and formats.76 Some health information 
technology companies have been working on solutions to 
overcome some of these issues, however, “the capabilities 
for pharmacies to interface with [IIS] at this level are still 
in the early stages”.75 Another limitation in technology that 
may create some challenges for community pharmacy-based 
immunization services is that PIMSs used by pharmacies are 
generally not equipped with patient scheduling and patient 
recommendation features based on the patient’s records. 
These features assist in patient follow-up and scheduling of 
vaccines that consist of multiple-dose series; they also help 
assist the pharmacist in prompting recommendations to the 
patients after the technology has queried the patient’s records 
for indications that may correlate with age, medications, and/
or diagnoses. These electronic clinical reminders are typically 
seen in electronic medical records and not in a PIMS.
Future considerations
Looking into the future, there are actions that can be taken 
to ensure the continual success and expansion of community 
pharmacy-based vaccination services. To do this, we should 
focus future efforts on education, national legislative changes, 
reimbursement design, integration of immunization workflow 
into a PIMS, and communication with the PCMH. As health 
care needs and public-health initiatives grow and change, the 
training and education of student and current pharmacists 
must also be revised to meet these changes  effectively. An 
increased emphasis on the role of pharmacists in public health 
will help pharmacists increase their credibility, expand their 
scope of practice at the micro- and macro-levels of public 
health, and hopefully provide pharmacist recognition and 
legislative changes at a national level as providers that are 
part of the PCMH.77–79 Ways to achieve this may be to incor-
porate public-health courses and public-health experiential 
education opportunities into the Pharm D curriculum, offer 
joint Pharm D and Master of Public Health (MPH) degree 
programs, increase continuing education topics in public 
health, and have pharmacists and pharmacy stakeholders 
participate in legislative actions.  It has been suggested that 
pharmacists functioning as vaccine educators and immu-
nizers could increase educational campaigns focusing on 
disparities and aimed at bridging the gap among racial and 
ethnic populations.61 Pharmacists can also expand beyond the 
community pharmacy to other  community settings (churches, 
malls, senior centers, colleges, workplaces, etc) and have these 
locations host an immunizing pharmacist.
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Legislative and regulatory changes that will benefit the 
future sustainability of community pharmacy-based  vaccination 
are standardized recognition for pharmacists to furnish all 
CDC-recommended vaccines to indicated patients as well as 
uniform provider recognition among benefit plans for improved 
reimbursement and  compensation. Other avenues for increasing 
performance may be to implement vaccine-related performance 
measures or incentives in immunizing pharmacists’ payer 
contracts. Although no states permit pharmacy technicians to 
administer vaccines, the pharmacy technician can serve a role 
in the pharmacy’s immunization services. Pharmacy techni-
cians can be delegated with tasks related to inventory, patient 
scheduling, and intake; prescription processing and payment; 
and administrative work. Engaging the pharmacy technician can 
minimize the time pharmacists spend on these areas and cause 
less disruption in the pharmacist’s normal  workflow. Another 
advancement that can assist in improving the pharmacists’ 
efforts and save time is the use of PIMS software that can pro-
vide electronic clinical alerts for patient immunization needs, 
send reports to the state IIS, and communicate with PCPs.
Conclusion
With the appropriate training/education, accessibility, and 
effective provision of immunizations in community phar-
macies, pharmacists are uniquely positioned to improve 
immunization rates and public-health efforts. Serving as 
immunization advocates in the roles of educators, facilitators, 
and immunizers, community pharmacists motivate patients to 
receive immunizations, enable other providers to immunize, 
and directly vaccinate the patients that they serve. Although 
much success has been seen in the past few decades, as evi-
denced by all pharmacists now being authorized to immunize, 
barriers such as variable scope of immunization practice 
for pharmacists across states, inconsistent reimbursement 
mechanisms, and barriers in technology still exist in this 
setting. Continued and future success in this area requires 
calls for action from educators, legislators, payers, and the 
health information technology community.
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